About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ultrasound Elastography of Breast Lesions | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00716482

Ultrasound Elastography of Breast Lesions

Our hypothesis is that the addition of ShearWave Elastography (SWE) to a conventional breast ultrasound examination provides useful information for the radiologist when imaging lesions in the breast, ...

Lead sponsor: SuperSonic Imagine•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

SuperSonic Imagine

Age

21 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•patients who have been referred to a breast ultrasound because of a positive physical palpation and/or positive mammograms and/or positive ultrasound and/or positive MRI.
•female
•age 21 or older
•provide informed consent

Exclusion Criteria

•Women who are unwilling or unable to provide informed consent
•Women with breast implants
•Women with superficial lesions or lesions on skin (with the most superficial surface of the lesion within 5 mm of the skin surface)
•Women who are pregnant or breastfeeding
•Women who are undergoing chemotherapy or radiotherapy for any cancer
•Women with previous breast conserving surgery on the breast of interest Note: Previous excision of a benign lesion 4 cm or more away from the suspected lesion does not constitute an exclusion criterion.

Related studies

RECRUITINGPhase 2

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098 · Breast Neoplasms

RECRUITINGPhase 2

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

NCT07222215 · Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, and more

Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction

NCT07230535 · Breast Cancer, Breast Neoplasms, Breast Reconstruction, and more

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery

NCT06608446 · Breast Neoplasms

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 9, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,681

Start dateJul 2008

Last updatedSep 9, 2013

Condition

Breast Neoplasms

Locations shown

University of Southern California - LAC+USC Medical Center, OPD Rm 3P61

Los Angeles, California

Sally Jobe Breast Center

Denver, Colorado

Yale Medical Center, Department of Diagnostic Radiology

New Haven, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions